Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience.
The Journal of dermatological treatment（2023）
摘要
The treatment of moderate-to-severe atopic dermatitis (AD) in the elderly population could be challenging due to their comorbidities and side effects of conventional systemic drugs.
更多查看译文
关键词
atopic dermatitis,dupilumab,elderly,treatment,real-life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要